News

Published on 10 May 2024 on Insider Monkey via Yahoo Finance

bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript

Article preview image

bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript May 9, 2024

bluebird bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Thank you for standing by, and welcome to the bluebird bio First Quarter 202 Results Call. [Operator Instructions] Finally, you are reminded that this conference is being recorded.

Read the rest of the article
NASDAQ.BLUE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
bluebird bio Inc (BLUE) Q3 2024 Earnings Call Highlights: Navigating Revenue...

Total Revenue: $10.6 million in Q3, down from $16.1 million in Q2. Projected Q4 Revenue: At least...

GuruFocus.com · via Yahoo Finance 14 Nov 2024
bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge...

Insider Monkey · via Yahoo Finance 31 Oct 2024
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well

bluebird bio BLUE registered revenues of $18.6 million in the first quarter, up from $2.4 million...

Zacks via Yahoo Finance 10 May 2024
bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript

bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript May 9, 2024 bluebird bio, Inc. ...

Insider Monkey via Yahoo Finance 10 May 2024
Earnings call: Bluebird bio reports Q1 2024 results, anticipates growth By Investing.com

Bluebird bio Inc. (BLUE) has announced its first-quarter 2024 financial results, highlighting the...

Investing.com 10 May 2024
bluebird bio reports first commercial gene therapy use By Investing.com

This development marks a major step in making the treatment accessible to patients with a history...

Investing.com 7 May 2024
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

Zoetis, Inc. ZTS is slated to report its first-quarter 2024 results on May 2, before market open....

Zacks via Yahoo Finance 25 Apr 2024
Walgreens specialty pharmacy launches with gene therapy unit

Walgreens Boots Alliance (WBA) expands specialty pharmacy services with dedicated unit for gene a...

Seeking Alpha 25 Apr 2024
Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarte...

Insider Monkey via Yahoo Finance 24 Apr 2024
bluebird (BLUE) Underperforms Industry YTD Amid Challenges

bluebird bio’s BLUE shares have lost 25.4% year to date compared with the industry’s decline of 7...

Zacks via Yahoo Finance 16 Apr 2024

Copyright Statfolio @ 2024

Social Accounts